Gene networks in basal cell carcinoma of the eyelid, analyzed using gene expression profiling
- 21 September 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (5) , 6729-6734
Abstract
Basal cell carcinoma (BCC) is the most frequent malignant tumor of the eyelid; it progresses slowly and rarely metastasizes. However, BCC of the eyelid is partially invasive and can extend to the surrounding ocular adnexa even if appropriate treatment is performed. To understand the molecular mechanism underlying its pathogenesis, global gene expression analysis of surgical tissue samples of BCC of the eyelid (n=2) and normal human epidermal keratinocytes was performed using a GeneChip® system. The histopathological examination of surgically removed eyelid tissues showed the tumor nest composed with small basaloid. In the samples from patients 1 and 2, 687 and 713 genes were identified, respectively, demonstrating ≥5.0‑fold higher expression than that noted in normal human epidermal keratinocytes. For the 640 genes with upregulated expression in both patient samples, Ingenuity® pathway analysis showed that the gene network in BCC of the eyelid included many BCC‑associated genes, such as the following: BCL2 apoptosis regulator; Patched‑1; and SRY‑box 9. In addition, unique gene networks related to cancer cell growth, tumorigenesis, and cell survival were identified. These results of integrating microarray analyses provide further insights into the molecular mechanisms involved in BCC of the eyelid and may provide a therapeutic approach for this disease.Keywords
This publication has 50 references indexed in Scilit:
- Cutaneous basal cell carcinosarcoma: case report and literature reviewJournal of Cutaneous Pathology, 2015
- ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling PathwayCancer Research, 2014
- NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAMProceedings of the National Academy of Sciences, 2013
- Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: A genomic approachInternational Journal of Oncology, 2012
- Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in gliomaOncogene, 2012
- Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial CellsMolecular Cancer Research, 2008
- Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cellsCell Death & Differentiation, 2004
- Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-β and Retinoic Acid*Endocrinology, 1997
- Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.Proceedings of the National Academy of Sciences, 1995
- Basal cell carcinoma of the eyelid and periocular skinSurvey of Ophthalmology, 1993